Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Investing in stocks, especially via ETFs and mutual funds, enables long-term wealth growth. Consider bonds for capital preservation and income as retirement approaches. Diversify investments across ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

When you think of the Hoosier State, race cars and corn might be top of mind, but Indiana is host to so much more. This sports hub is home to the annual Indianapolis 500, the NCAA headquarters and ...

May 10, 2026 Larry Wansley, pt. 1 (Ep. 24, 2026) This week on In Black America, producer and host John L. Hanson, Jr. begins a conversation with Larry Wansley, former Marine, Compton, California ...